| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4578cec3d49cbd6eab7015ef0ab688c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2010-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49e9ca618ca378283b7287ab053be519 |
| publicationDate |
2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010136568-A1 |
| titleOfInvention |
Compositions and Methods for Regulating RNA Translation via CD154 CA-Dinucleotide Repeat |
| abstract |
Compositions and methods for regulating CD154 gene expression are provided that rely on the interaction of hnRNP L with the CA-dinucleotide rich sequence of the 3′-untranslated region of CD154. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011219130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011219062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019118497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8166181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9662314-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8171145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013059606-A1 |
| priorityDate |
2005-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |